RecruitingNot ApplicableNCT06073626

Addressing Genomic Disparities in Cancer Survivors


Sponsor

Rutgers, The State University of New Jersey

Enrollment

428 participants

Start Date

Jul 31, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this observational study is to increase genetic education and genetic testing for hereditary cancer risk among Black cancer survivors. The study will: 1. Test the effectiveness of a chatbot intervention (also called relational agent, or RA) vs. enhanced usual care (EUC) on engagement in genetic education and requests for genetic testing. 2. Evaluate the impact of the chatbot vs. EUC on the process that participants use to make decisions and evaluate effects on well-being (also called psychosocial outcomes). 3. Explore the ways (methods) that influence how participants experience the intervention. 4. Explore the feasibility of incorporating a Family Sharing Portal (FSP) for participants who receive a positive test result, to facilitate family communication of these test results and genetic testing of first-degree biological relatives after they have received genetic education by the RA. The main questions this study aims to answer are which group - the chatbot (RA) group or the EUC group - is more likely to request genetic testing and which group is more likely to get (engage with) genetic education. Participants will be randomly assigned to either the chatbot (RA) group or EUC group. This means each participant has an equal chance of being placed in either group, just like flipping a coin. Each group will receive genetic education and have an opportunity to request genetic testing. Researchers will compare the chatbot (RA) group and the EUC group to see which may request more GT (genetic testing) and which group engages more with genetic education.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria10

  • -80 years of age
  • Self-identify as Black or African American
  • At least 6-months post diagnosis with any of the following cancers: breast, ovarian, uterine, prostate, colorectal, pancreatic
  • Have not had genetic testing for hereditary cancer
  • Have received care at one of the participating sites in the prior five years
  • Meet National Comprehensive Cancer Network criteria for germline GT
  • Able to read and speak in English
  • Capable of providing informed consent
  • Have internet access (via smartphone, tablet or computer)
  • Comfortable using a computer or mobile phone independently to access information

Exclusion Criteria4

  • Do not speak English
  • Unable to access the Internet
  • Have previously undergone germline genetic testing for hereditary cancer risk or previously had genetic counseling (GC) and declined genetic testing (GT)
  • Are unable to provide informed consent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALRelational agent (RA) / Chatbot

Consists of clinical letter and engagement with genetic education and uptake of genetic testing for hereditary cancer risk among Black cancer survivors.

BEHAVIORALEnhanced Usual Care (EUC)

Consists of clinical letter and recommendation for genetic testing for hereditary cancer risk among Black cancer survivors.


Locations(2)

Georgetown Lombardi Comprehensive Cancer Center

Washington D.C., District of Columbia, United States

Rutgers Cancer Institute

New Brunswick, New Jersey, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06073626


Related Trials